Index trend and stocks in action on March 30, 2020
Index trend and stocks in action on March 30, 2020

Index trend and stocks in action on March 30, 2020

DSIJ Intelligence-3 Article rating: 5.0

The high to low range of the last week becomes crucial which stands at 7,511 to 9,039 levels. As long as we stay within this range, we can expect the markets to consolidate. Stocks in news: Sun Pharmaceutical, Motherson Sumi systems, Manappuram Finance, NTPC, Delta Corp, Lupin and Laurus Labs.

Be ready for the bear attack!
Be ready for the bear attack!

Be ready for the bear attack!

DSIJ Intelligence-3 Article rating: 2.5

Welcome to the fresh week on D-Street! The markets ended the last trading session near the day’s low and gave away the entire decent gains post RBI announcement. Over the weekend, if market participants were hoping for some Monday Magic to revive the sentiments on D-Street, which lost its pace after RBI announcement then, they will be certainly disappointed.

Aurobindo Pharma gains on getting EIR from USFDA
Aurobindo Pharma gains on getting EIR from USFDA

Aurobindo Pharma gains on getting EIR from USFDA

Avalokita Pandey Article rating: 4.7

Aurobindo Pharma gained around 12 per cent to Rs 406 on Friday after the company informed that it has received an EIR from USFDA for its Hyderabad facility. The company also informed that it has received USFDA approval for its muscle relaxant-Tizanidine Hydrochloride. Soon after this approval, the stock hit an upper circuit of Rs 397.50 per share. 

Dr Reddys board approve Rs 2,000 crore borrowing
Dr Reddys board approve Rs 2,000 crore borrowing

Dr Reddys board approve Rs 2,000 crore borrowing

Avalokita Pandey Article rating: 2.8

Dr Reddy’s Laboratories announced that its board of directors have given its approval to the company for borrowing up to Rs 2,000 crore, as part of fund-raising plans. 

Lupin & Mylan announce CHMP opinion for Nepexto
Lupin & Mylan announce CHMP opinion for Nepexto

Lupin & Mylan announce CHMP opinion for Nepexto

DSIJ Intelligence Article rating: 4.4

Lupin Limited and Mylan NV (NASDAQ: MYL) announced that European Medicines Agency's committee for medicinal products for human use (CHMP) has adopted a positive opinion recommending the approval of Nepexto, a biosimilar to Enbrel.

Brent Crude spills again!
Brent Crude spills again!

Brent Crude spills again!

DSIJ Intelligence Article rating: 5.0

The spread of Coronavirus has been getting more and more serious globally, with continuous speedy rise in the new infected cases as well as death count. This has resulted into various countries applying travel restrictions as well as suspending international or domestic travel thereby, causing a worldwide slashed in fuel demand. As a result, Brent Crude witnessed a dip in prices and was last seen trading at USD 28.36 per barrel.

Balrampur Chini Mills gain after ICICI Bank invests in NBFC arm
Balrampur Chini Mills gain after ICICI Bank invests in NBFC arm

Balrampur Chini Mills gain after ICICI Bank invests in NBFC arm

Avalokita Pandey Article rating: 4.5

ICICI Bank Limited informed that it has entered into an agreement to invest Rs 51.09 crore in Balrampur Chini Mills’ associate company-Auxilo Finserve Private Limited. Post this investment, Balrampur Chini Mills was today locked in 10 per cent upper circuit at Rs 90.

Jubilant FoodWorks bounce from upward sloping trendline support
Jubilant FoodWorks bounce from upward sloping trendline support

Jubilant FoodWorks bounce from upward sloping trendline support

Vinayak Gangule Article rating: 4.2

Considering the weekly timeframe, the stock of Jubilant FoodWorks Limited has bounced back from the edge of the rising trendline support that is formed by connecting the swing lows from October 2018 and coinciding with long-term moving average, i.e. 200-week EMA level. 

RSS
First31113112311331143116311831193120Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR